Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Walker

Showing results (61-70 of 490) with videos related to

Pageof 49
Sort By:
AIDS (London, England)|April 13, 2004
Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?Don E Smith, Bruce D Walker, David A Cooper, et al.
AIDS (London, England)|August 10, 2012
Identification of HIV-1-specific regulatory T-cells using HLA class II tetramersMathieu Angin, Melanie King, Marcus Altfeld, et al.
Immunity|March 26, 2013
Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen designAndrew L Ferguson, Jaclyn K Mann, Saleha Omarjee, et al.
Journal of Virology|May 26, 2018
Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral LoadOmolara Baiyegunhi, Bongiwe Ndlovu, Funsho Ogunshola, et al.
The Journal of Biological Chemistry|May 17, 2006
Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytesErik Martinez-Hackert, Nadia Anikeeva, Spyros A Kalams, et al.
Journal of Leukocyte Biology|July 14, 2016
Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressorsDavid Shasha, Dan Karel, Olivia Angiuli, et al.
Immunology|November 24, 2004
Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytesTatiana Lebedeva, Nadja Anikeeva, Spyros A Kalams, et al.
Nature Immunology|April 20, 2018
Resistance of HIV-infected macrophages to CD8<sup>+</sup> T lymphocyte-mediated killing drives activation of the immune systemKiera L Clayton, David R Collins, Josh Lengieza, et al.
American Heart Journal|November 8, 2002
Sex differences in QTc interval and QT dispersion: dynamics during exercise and recovery in healthy subjectsVijay S Chauhan, Andrew D Krahn, Bruce D Walker, et al.
Journal of Virology|May 22, 2015
Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like PropertiesSelena Vigano, Jordi Negron, Zhengyu Ouyang, et al.
Pageof 49

Showing results (61-70 of 490) with videos related to

Sort By:
Pageof 49
AIDS (London, England)|April 13, 2004
Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?Don E Smith, Bruce D Walker, David A Cooper, et al.
AIDS (London, England)|August 10, 2012
Identification of HIV-1-specific regulatory T-cells using HLA class II tetramersMathieu Angin, Melanie King, Marcus Altfeld, et al.
Immunity|March 26, 2013
Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen designAndrew L Ferguson, Jaclyn K Mann, Saleha Omarjee, et al.
Journal of Virology|May 26, 2018
Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral LoadOmolara Baiyegunhi, Bongiwe Ndlovu, Funsho Ogunshola, et al.
The Journal of Biological Chemistry|May 17, 2006
Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytesErik Martinez-Hackert, Nadia Anikeeva, Spyros A Kalams, et al.
Journal of Leukocyte Biology|July 14, 2016
Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressorsDavid Shasha, Dan Karel, Olivia Angiuli, et al.
Immunology|November 24, 2004
Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytesTatiana Lebedeva, Nadja Anikeeva, Spyros A Kalams, et al.
Nature Immunology|April 20, 2018
Resistance of HIV-infected macrophages to CD8<sup>+</sup> T lymphocyte-mediated killing drives activation of the immune systemKiera L Clayton, David R Collins, Josh Lengieza, et al.
American Heart Journal|November 8, 2002
Sex differences in QTc interval and QT dispersion: dynamics during exercise and recovery in healthy subjectsVijay S Chauhan, Andrew D Krahn, Bruce D Walker, et al.
Journal of Virology|May 22, 2015
Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like PropertiesSelena Vigano, Jordi Negron, Zhengyu Ouyang, et al.
Pageof 49